Driclor may cause irritation which may be alleviated by use of a weak corticosteroid cream.
Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency. Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 and <1/10), uncommon (≥ 1/1,000 and <1/100), rare (≥ 1/10,000 and <1/1,000), very rare (<1/10,000), and not known (cannot be estimated from the available data).
Clinical Trial Data
Skin and Subcutaneous Tissue Disorders
Very common: | Application site irritation |
Post Marketing Data
Immune System Disorders
Not known: | Application site hypersensitivity including application site dermatitis |
Skin and Subcutaneous Tissue Disorders
Not known: | Application site reactions including pain, pruritus, erythema, rash and skin burning sensation |
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at:www.mhra.gov.uk/yellowcard